GSK Plc (GLAXF)
GSK Market Cap: 96.46B for Jan. 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 1.879M |
| NuCana Plc | 13.78M |
| Autolus Therapeutics Plc | 367.28M |
| Tiziana Life Sciences Ltd. | 201.95M |
| Aptorum Group Ltd. | 7.358M |
Market Cap Related Metrics
| PE Ratio | 13.69 |
| PS Ratio | 2.353 |
| PEG Ratio | 0.1069 |
| Price to Book Value | 4.437 |
| Price to Free Cash Flow | 17.61 |
| Price | 24.00 |
| Earnings Yield | 7.30% |
| PEGY Ratio | 0.104 |
| Operating PE Ratio | 10.02 |
| Normalized PE Ratio | 12.11 |